Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2010
11/11/2010WO2010129674A2 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
11/11/2010WO2010129671A2 Method of and apparatus for changing one type of cell into another type of cell
11/11/2010WO2010128793A2 Fat soluble vitamin and a derivative thereof induced by novel cationic chitosan, a method of producing same and drug delivery system containing same
11/11/2010WO2010128669A1 Gene transfer agent composition containing polyamidoamine dendron
11/11/2010WO2010128182A1 Oncolytic adenoviruses for treating cancer
11/11/2010WO2010127400A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
11/11/2010WO2010079978A3 Composition for improving inflammatory disease using abh antigens
11/11/2010US20100286253 Method for treating ocular neovascularization
11/11/2010US20100286252 Human fg01 gene and its applications
11/11/2010US20100286250 Fluorinated lipids and methods of use
11/11/2010US20100286246 Identification of novel genes coding for small temporal rnas
11/11/2010US20100286245 Identification of novel genes coding for small temporal rnas
11/11/2010US20100286244 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY
11/11/2010US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
11/11/2010US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
11/11/2010US20100285590 Homologous Recombination in Multipotent Adult Progenitor Cells
11/11/2010US20100285529 Feline granulocyte macrophage colony stimulating factor proteins
11/11/2010US20100285499 HUMAN p51 GENES AND GENE PRODUCTS THEREOF
11/11/2010US20100285132 Immunotherapy compositions, method of making and method of use thereof
11/11/2010US20100285023 Detecting cyp24 expression level as a marker for predisposition to cancer
11/11/2010US20100284978 Cultures, products and methods using umbilical cord matrix cells
11/11/2010CA2761614A1 Human fg01 gene and its applications
11/11/2010CA2761248A1 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
11/11/2010CA2761183A1 Oncolytic adenoviruses for treating cancer
11/11/2010CA2761152A1 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
11/11/2010CA2759801A1 Gene therapy for neurodegenerative disorders
11/10/2010EP2248900A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/10/2010EP2247731A2 Aptamer inhibitors of osteopontin and methods of use thereof
11/10/2010EP2247311A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials
11/10/2010EP2247309A2 Tapasin augmentation for enhanced immune response
11/10/2010EP2247258A1 Rescue of photoreceptors by intravitreal administation of an expression vector encoding a therapeutic protein
11/10/2010EP2073849B1 Methods and compositions for gene therapy
11/10/2010EP1947195B1 Method for the in vitro detection of a predisposition to the development of alterations in ovarian function
11/10/2010EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof
11/10/2010EP1265915B1 Novel compounds
11/10/2010CN1798840B Nogo受体结合蛋白 Nogo receptor-binding protein
11/10/2010CN1784248B Needleless syringe having medical agent accommodated therein
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN101883859A Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
11/10/2010CN101883858A Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof
11/10/2010CN101883576A A micro-rna family that modulates fibrosis and uses thereof
11/10/2010CN101880688A Method for selectively replicating replication-defective adenovirus and application
11/10/2010CN101880677A siRNA sequence against 2009 new influenza A virus polymerase gene and nucleoprotein gene and application thereof
11/10/2010CN101880397A Cross linking polymer and preparation method thereof
11/10/2010CN101880328A Th multi-epitope gene and fusion protein of cryptosporidium parvum and application thereof
11/10/2010CN101879317A Preparation method and application of Vibro harveyi and Vibrio parahaemolyticus bigeminy DNA vaccine
11/10/2010CN101879316A Genetic engineering vaccine as well as preparation method and application thereof in pharmacy
11/10/2010CN101879160A Application of 3-substituted aryl oxindole in multidrug resistance tumor cells
11/10/2010CN101643750B Construction method and applications of targeting oncolytic-adenovirus carier Ad-TD-gene
11/10/2010CN101422619B New method for preventing tumor cell growth based on nucleus binding-protein gene silencing
11/10/2010CN101199852B Polyethyleneimine of non-iron surfactant modifying, preparing and application
11/10/2010CN101104856B Series of non-viral vectors and pharmaceutical composition containing the same
11/09/2010US7829695 Specific GRP78 expression-inhibition RNAi sequence, medicine thereof and method thereof
11/09/2010US7829694 surgerical insertion of catheter; supplying protein antagonistl Alzheimer's disease; Parkinson's disease; Huntington's disease; Spinocerebella atropy
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829685 Regulation of kinase, regulated in COPD kinase (RC kinase)
11/09/2010US7829676 Whitefly ecdysone receptor antibody
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829672 Modulation of sodium channels in dorsal root ganglia
11/09/2010US7829664 encoding a human pro-insulin leader, a glucagon-like peptide-1 (GLP-1), and a furin cleavable site between the human pro-insulin leader sequence and the GLP-1; Type II diabetes, hyperglycemia; reducing weight in a subject by implanting into the subject an immunoisolatory device
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829537 drug biological conjugates used in the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers
11/09/2010US7829536 administering to a patient with lymphedema a therapeutically effective amount of a vascular endothelial growth factor D (VEGF-D) protein at the site of edema, that binds and stimulates wild-type VEGFR-3; genetic disorders; screening
11/09/2010US7829329 Adenoviral vectors for treating disease
11/09/2010US7829078 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery; increasing the hematocrit and/or the reticulocyte count in a mammalian subject
11/09/2010CA2386242C Tumour-specific vector for gene therapy
11/09/2010CA2343102C Antisense modulation of survivin expression
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/04/2010WO2010126246A2 ANTI ErbB2 RNA APTAMER AND APPLICATIONS THEREFOR
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010125544A1 Immunogenic nanomedicine composition and preparation and uses thereof
11/04/2010WO2010125527A1 Method for production of anti-tumor trail protein
11/04/2010WO2010125471A2 Gene vector
11/04/2010WO2010125358A1 Method for diagnosing and treating muscular dystrophy
11/04/2010WO2010125293A1 Targeting nucleic acids in the mitochondria
11/04/2010WO2010124365A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010US20100280282 Phosphatidyl oligoglycerols
11/04/2010US20100280105 Detection of mage-a expression
11/04/2010US20100279947 Modifications of apoptin
11/04/2010US20100279940 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100278871 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods
11/04/2010US20100278773 Chimeric flavivirus vaccines
11/04/2010DE10106493B4 Verfahren zur Herstellung von Nukleinsäuren Process for the preparation of nucleic acids
11/04/2010CA2760589A1 Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
11/04/2010CA2760482A1 Method for production of anti-tumor trail protein
11/04/2010CA2760042A1 Compositions and methods for modulating stem cells and uses thereof
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246413A2 Method for purifying plasmid DNA having pharmaceutical quality
11/03/2010EP2246358A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246357A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
11/03/2010EP2246069A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
11/03/2010EP2245142A2 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity
11/03/2010EP2244740A1 Compositions for enhanced uptake of viral vectors in the myocardium
11/03/2010EP1755567B1 Drug delivery product and methods
11/03/2010EP1741792B1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1478664B1 Tissue specific expression
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 870